Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2002 Nov 12;10(1):11–26. doi: 10.1016/0166-3542(88)90011-3

Loss of cytomegalovirus infectivity after treatment with castanospermine or related plant alkaloids correlates with aberrant glycoprotein synthesis

DL Taylor 1,5, LE Fellows 2, GH Farrar 3, RJ Nash 2, D Taylor-Robinson 1, MA Mobberley 4, TA Ryder 4, DJ Jeffries 5, AS Tyms 5
PMCID: PMC7134106  PMID: 2852915

Abstract

Many plants contain polyhydroxyalkaloids which are potent inhibitors of glucosidases, enzymes involved in oligosaccharide trimming. These are important in determining the final configuration of specific glycoproteins. Human cytomegalovirus (CMV) encodes a number of glycoproteins, some of which ultimately reside in the outer envelope of the mature virion and are important for virus infectivity. Treatment with three polyhydroxyalkaloids, castanospermine (CAST), deoxynojirimycin (DNJ) and 2R,5R-dihydroxymethyl-3R, 4R-dihydroxypyrrolidine (DMDP) blocked the growth of infectious virus, as determined by yield reduction and plaque reduction assays. However, in the presence of CAST, CMV infected cells continued to shed virions into the extracellular medium, as determined by electron microscopy. Envelope glycoproteins of virions produced after treatment with CAST (2.5 mM) were immunoprecipitated with a monoclonal antibody (F5) specific for the gcI family of glycoproteins. Analysis by PAGE-SDS showed an absence of gcI complex 2 (gp52 disulphide-linked to gp130) with a proportional increase in gcI complex 1 (gp52 disulphide-linked to gp95). The results indicated that gp130 alone, or linked to gp52, was important for CMV infectivity. As well as being potential targets for antiviral agents against CMV, inhibitors of glycoprotein trimming reactions may define components of the virion surface important for infectivity.

Keywords: Cytomegalovirus; Glycoprotein complex; Inhibitor, glycoprotein processing enzyme; Castanospermine; Deoxynojirimycin

References

  1. Betts R.F. Cytomegalovirus infection in transplant patients. Progr. Med. Virol. 1982;28:44–64. [PubMed] [Google Scholar]
  2. Blough H.A., Giuntoli R.L. Successful treatment of human genital herpes infections with 2-deoxy-D-glucose. J. Am. Med. Assoc. 1979;241:2798–2801. [PubMed] [Google Scholar]
  3. Blough H.A., Pauwels R., DeClerq E., Cogniaux J., Sprecher-Goldberger S., Thiry L. Glycosylation inhibitors block the expression of LAV/HTLV III (HIV) glycoproteins. Biochem. Biophys. Res. Commun. 1986;141:33–38. doi: 10.1016/s0006-291x(86)80330-8. [DOI] [PubMed] [Google Scholar]
  4. Britt W.J. Neutralizing antibodies detect a disulphidelinked glycoprotein complex within the envelope of human cytomegalovirus. Virology. 1984;135:369–378. doi: 10.1016/0042-6822(84)90193-4. [DOI] [PubMed] [Google Scholar]
  5. Burke B., Matlin K., Bause E., Legler G., Peyrieras N., Ploegh H. Inhibition of N-linked oligosaccharide trimming does not interfere with surface expression of certain integral membrane proteins. Eur. Mol. Biol. Organ. J. 1984;3:551–556. doi: 10.1002/j.1460-2075.1984.tb01845.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Courtney R.J., Steiner S.M., Benyesh-Melnick M. Effect of 2-deoxy-D-glucose on herpes simplex virus replication. Virology. 1975;52:447–455. doi: 10.1016/0042-6822(73)90340-1. [DOI] [PubMed] [Google Scholar]
  7. Elbein A.D., Mitchell M., Sanford B.A., Fellows L.E., Evans S.V. The pyrrolidine alkaloid 2,5-dihydroxymethyl-3,4-dihydroxypyrrolidine inhibits glycoprotein processing. J. Biol. Chem. 1984;259:12409–12413. [PubMed] [Google Scholar]
  8. Farrar G.H., Oram J.D. Characterisation of the human cytomegalovirus envelope glycoproteins. J. Gen. Virol. 1984;65:1991–2001. doi: 10.1099/0022-1317-65-11-1991. [DOI] [PubMed] [Google Scholar]
  9. Farrar G.H., Greenaway P.J. Characterisation of glycoprotein complexes present in human cytomegalovirus envelopes. J. Gen. Virol. 1986;67:1469–1473. doi: 10.1099/0022-1317-67-7-1469. [DOI] [PubMed] [Google Scholar]
  10. Fellows L.E. The biological activity of polyhydroxyalkaloids from plants. Pestic. Sci. 1986;17:602–606. [Google Scholar]
  11. Furhmann U., Bause E., Ploegh H. Inhibitors of oligosaccharide processing. Biochem. Biophys. Acta. 1985;825:95–110. doi: 10.1016/0167-4781(85)90095-8. [DOI] [PubMed] [Google Scholar]
  12. Gretch D.R., Kari B., Rasmussen L., Gehrz R.C., Stinski M.F. Identification and characterisation of three distinct families of glycoprotein complexes present in the envelopes of human cytomegalovirus. J. Virol. 1988;62:875–881. doi: 10.1128/jvi.62.3.875-881.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gretch D.R., Gehrz R.C., Stinski M.F. Characterisation of a human cytomegalovirus glycoprotein complex (gc1) J. Gen. Virol. 1988;69:1205–1215. doi: 10.1099/0022-1317-69-6-1205. [DOI] [PubMed] [Google Scholar]
  14. Gruters R.A., Neefjes J.J., Tersmette M., Goede R.E.Y., Tulp A., Huisman H.G., Miedema F., Ploegh H.L. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature (London) 1987;330:74–77. doi: 10.1038/330074a0. [DOI] [PubMed] [Google Scholar]
  15. Hunter W.M., Greenwood F.C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature (London) 1962;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  16. Joubert P.H., Bam W.J., Mayane N. Effect of an alpha-glucosidase inhibitor (BAY m 1099) on post prandial blood glucose and insulin in type II diabetics. Euro. J. Clin. Pharmacol. 1986;30:253–255. doi: 10.1007/BF00614315. [DOI] [PubMed] [Google Scholar]
  17. Kari B., Lussenhop N., Goertz R., Wabuke-Bunoti M., Radeke R., Gehrz R. Characterization of monoclonal antibodies reactive to several biochemically distinct human cytomegalovirus glycoprotein complexes. J. Virol. 1986;60:345–352. doi: 10.1128/jvi.60.2.345-352.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kilbourne E.D. Inhibition of influenza virus multiplication with a glucose antimetabolite (2-deoxy-D-glucose) Nature (London) 1959;183:271–272. doi: 10.1038/183271b0. [DOI] [PubMed] [Google Scholar]
  19. Law K.M., Witton-Smith P., Farrar G. A murine monoclonal antibody recognising a single glycoprotein within a human cytomegalovirus virion envelope glycoprotein complex. J. Med. Virol. 1985;17:255–266. doi: 10.1002/jmv.1890170307. [DOI] [PubMed] [Google Scholar]
  20. Meyers J.D., Fleurnoy N., Thomas E.D. Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years experience. Rev. Infect. Dis. 1982;4:1119–1132. doi: 10.1093/clinids/4.6.1119. [DOI] [PubMed] [Google Scholar]
  21. McDowell W., Romero P.A., Datema R., Schwarz R.T. Glucose trimming and mannose trimming affect different phases of the maturation of sindbis virus in infected BHK cells. Virology. 1987;161:37–44. doi: 10.1016/0042-6822(87)90168-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mobberley A.M., Ryder T.A., Hart H., Tyms A.S. Fine structure of cells infected with human cytomegalovirus after treatment with 9-(1,3-dihydroxy-2-propoxymethyl)guanine. J. Gen. Virol. 1987;68:1553–1562. doi: 10.1099/0022-1317-68-6-1553. [DOI] [PubMed] [Google Scholar]
  23. Pan Y.T., Hori H., Saul R., Sanford B.A., Molyneux R.J., Elbein A.D. Castanospermine inhibits the processing of the oligosaccharide portion of the influenza viral haemagglutinin. Biochemistry. 1983;22:3975–3984. doi: 10.1021/bi00285a038. [DOI] [PubMed] [Google Scholar]
  24. Pereira L., Hoffman M., Cremer N. Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus infected cell extracts by human sera. Infect. Immun. 1982;36:933–942. doi: 10.1128/iai.36.3.933-942.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Pinter A., Honnen W.J., Li J.S. Studies with inhibitors of oligosaccharide processing indicate a functional role for complex sugars in the transport and proteolysis of friend mink cell focusinducing murine leukaemia virus envelope proteins. Virology. 1984;136:196–210. doi: 10.1016/0042-6822(84)90259-9. [DOI] [PubMed] [Google Scholar]
  26. Rasmussen L.E., Nelson R.M., Kelsall D.C., Merigan T.C. Vol. 81. 1984. Murine monoclonal antibody to a single protein neutralises the infectivity of human cytomegalovirus; pp. 876–880. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rasmussen L., Mullenax J., Nelson R., Merigan T.C. Viral polypeptides detected by a complement dependent neutralising monoclonal antibody to human cytomegalovirus. J. Virol. 1985;55:274–280. doi: 10.1128/jvi.55.2.274-280.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Repp R., Tamura T., Boschek C.B., Wege H., Schwarz R., Niemann H. The effects of processing inhibitors of N-linked oligosaccharides on the intracellular migration of glycoprotein E2 mouse hepatitis virus and the maturation of coronavirus particles. J. Biol. Chem. 1985;260:15873–15879. doi: 10.1016/S0021-9258(17)36339-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Saul R., Ghidani J.J., Molyneux R.J., Elbein A.D. Vol. 82. 1985. Castanospermine inhibits α-glucosidase activities and alters glycogen distribution in animals; pp. 93–97. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Saunier B., Kilker R.D., Tkacz J.S., Quaroni A., Herscovics A. Inhibition of N-linked complex oligosaccharide formation by 1-deoxynojirimycin, an inhibitor of processing glucosidases. J. Biol. Chem. 1982;257:14155–14161. [PubMed] [Google Scholar]
  31. Schnack C., Roggla G., Luger A., Schernthaner G. Effects of the α-glucosidase inhibitor 1 desoxynojirimycin (BAY m 1009) on post prandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients. Eur. J. Clin. Pharmacol. 1986;30:417–419. doi: 10.1007/BF00607953. [DOI] [PubMed] [Google Scholar]
  32. Schwarz R.T., Klenk H.D. Inhibition of glycosylation of the influenza virus haemagglutinin. J. Virol. 1974;14:1023–1034. doi: 10.1128/jvi.14.5.1023-1034.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Schwarz R.T., Rohrschneider J.M., Schmidt M.F.G. Suppression of glycoprotein formation of Semliki forest, influenza and avian sarcoma virus by tunicamycin. J. Virol. 1976;19:782–791. doi: 10.1128/jvi.19.3.782-791.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Scofield A.M., Fellows L.E., Nash R.J., Fleet G.W.J. Inhibition of mammalian digestive disaccharidases by polyhydroxy alkaloids. Life Sci. 1986;39:645–650. doi: 10.1016/0024-3205(86)90046-9. [DOI] [PubMed] [Google Scholar]
  35. Stagno S., Reynolds D.W., Tsiantos A., Fuccillo D.A., Long W., Alford C.A. Comparative serial virologic and serologic studies of symptomatic and sub-clinical congenitally and natally acquired cytomegalovirus infections. J. Infect. Dis. 1975;132:568–577. doi: 10.1093/infdis/132.5.568. [DOI] [PubMed] [Google Scholar]
  36. Stinski M.F. Human cytomegalovirus: glycoproteins associated with virions and dense bodies. J. Virol. 1976;19:594–609. doi: 10.1128/jvi.19.2.594-609.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Stinski M.F. Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus. J. Virol. 1977;23:751–767. doi: 10.1128/jvi.23.3.751-767.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sunkara P.S., Bowlin T.L., Liu P.S., Sjoerdsma A. Antiretroviral activity of castanospermine and deoxynojirimycin, specific inhibitors of glycoprotein processing. Biochem. Biophys. Res. Commun. 1987;148:206–210. doi: 10.1016/0006-291x(87)91096-5. [DOI] [PubMed] [Google Scholar]
  39. Tyms A.S., Williamson J.D. Polyamine metabolism in MRC-5 cells infected with human cytomegalovirus. J. Gen. Virol. 1980;48:183–191. doi: 10.1099/0022-1317-48-1-183. [DOI] [PubMed] [Google Scholar]
  40. Tyms A.S., Berrie E.M., Ryder T.A., Nash R.J., Hegarty M.P., Taylor D.L., Mobberley M.A., Davis J.M., Bell E.A., Jeffries D.J., Taylor-Robinson D., Fellows L.E. Castanospermine and other plant alkaloid inhibitors of glucosidase activity block the growth of HIV. Lancet. 1987;II:1025–1026. doi: 10.1016/s0140-6736(87)92588-8. [DOI] [PubMed] [Google Scholar]
  41. Tyms A.S., Taylor D.L., Parkin J.M. Cytomegalovirus and the acquired immunodeficiency syndrome. J. Antimicrob. Chemother. 1988 doi: 10.1093/jac/23.suppl_a.89. (in press.) [DOI] [PubMed] [Google Scholar]
  42. Walker B.D., Kowalski M., Goh W.C., Kozarsky K., Krieger M., Rosen C., Rohrschneider L., Haseltine W.A., Sodroski J. Vol. 84. 1987. Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine; pp. 8120–8124. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antiviral Research are provided here courtesy of Elsevier

RESOURCES